Comparison of Retinal Damage in ICL Implantation Using 3D Visualization System vs. Microscope
Comparison of Ngenuity and Traditional Microscopy in Assessing Retinal Function Recovery Post-ICL Surgery
1 other identifier
interventional
40
0 countries
N/A
Brief Summary
Implantable collamer lens (ICL) implantation is considered one of the most effective surgical treatments for high myopia. The procedure primarily involves adjusting the position of the ICL within the eye. However, precise calculation of the ICL optical power may cause the surgical light source to remain focused on the macular area during this process, potentially leading to iatrogenic light-induced damage. Theoretically, the combination of a 3D visualization surgical system and coaxial illumination technology can reduce the illumination intensity and decrease iatrogenic light damage. This study aims to compare the retinal physiological changes in patients undergoing ICL surgery through 3D visualization surgical system with coaxial illumination versus a traditional microscope with standard illumination.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2025
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 4, 2025
CompletedFirst Posted
Study publicly available on registry
May 13, 2025
CompletedStudy Start
First participant enrolled
August 25, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2026
ExpectedAugust 8, 2025
May 1, 2025
3 months
May 4, 2025
August 7, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
b-wave amplitude
1 day pre-op; 1 day post-op; 7 days post-op; 30 days post-op
Secondary Outcomes (4)
a-wave amplitude
1 day pre-op; 1 day post-op; 7 days post-op; 30 days post-op
macular vessel density
1 day pre-op; 1 day post-op; 7 days post-op; 30 days post-op
Uncorrected visual acuity
1 day pre-op; 1 day post-op; 7 days post-op; 30 days post-op
Best-corrected visual acuity
1 day pre-op; 1 day post-op; 7 days post-op; 30 days post-op
Other Outcomes (2)
Intraoperative illumination intensity
surgery beginning
Surgical time
Starting with the making of the surgical incision and ending with incision closure
Study Arms (2)
3D visualization system
EXPERIMENTALMicroscope
ACTIVE COMPARATORInterventions
operation through 3D visualization system with coaxial illumination
operation through microscope with standard illumination
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of high myopic
- Aged 18-40 years
- Desire to improve their refractive status via ICL surgery
- Relatively stable refractive error (change ≤ 0.50 D per year for two consecutive years)
- Central anterior chamber depth ≥ 2.8 mm
- Open angles
- Corneal endothelial cell density ≥ 2000 cells/mm2.
You may not qualify if:
- Cataracts
- Corneal diseases,
- Glaucoma,
- Nystagmus,
- Strabismus,
- Lens subluxation,
- Severe vitreoretinal diseases,
- Other ocular diseases
- A history of ocular trauma
- A history of ocular surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fuzhou Eye Hospitallead
- Alcon Researchcollaborator
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 4, 2025
First Posted
May 13, 2025
Study Start
August 25, 2025
Primary Completion
November 30, 2025
Study Completion (Estimated)
May 31, 2026
Last Updated
August 8, 2025
Record last verified: 2025-05